阿利司帝是Takeda開發(fā)的一種口服選擇性極光激酶抑制劑。研究了復(fù)發(fā)或難治性外周T細(xì)胞淋巴瘤的治療方法。
(2-Amino-5-chlorophenyl)(2,6-difluorophenyl)methanone
(5-Chloro-2-iodophenyl)(2,6-difluorophenyl)methanone
4-Bromo-2-methoxybenzoic acid
4-Guanidino-2-methoxybenzoic acid
Methyl 4-amino-2-methoxybenzoate
(5-Chloro-2-iodophenyl)(2-fluoro-6-methoxyphenyl)methanone
4-Guanidino-2-methoxybenzoic Acid Hydrochloride
tert-Butyl (3-(4-chloro-2-(2-fluoro-6-methoxybenzoyl)phenyl)prop-2-yn-1-yl)carbamate
